Singapore's Thomson Medical Group FY revenue rises on Singapore strength, Malaysia oncology contribution

Thomson Medical

26/08/2026 10:34

Overview
Singapore healthcare provider's FY2026 revenue grew 6.4% yr/yr, driven by regional expansion
Adjusted EBITDA for the year rose 9.9% to S$82.5 mln
Net loss narrowed 40.8% to S$27.8 mln on stronger operating performance

Outlook
Company will focus on strengthening execution and expanding specialist services across its portfolio
Thomson Medical sees growth momentum in Malaysia and patient volumes rising in Vietnam
Company will maintain disciplined investment and capital allocation for sustainable long-term earnings

Result Drivers
MALAYSIA EXPANSION - Co said revenue growth was driven by full-year contribution from Oncology Centre and expanded specialist services in Malaysia
SINGAPORE OPERATIONS - Co attributed improved operating performance to higher revenue intensity and greater pricing discipline in Singapore
VIETNAM PATIENT VOLUMES - Co said higher patient volumes in Vietnam contributed to revenue growth, though offset by unfavorable exchange rate impact

Company press release: ID:nSN5nD4HY

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY Net Loss
 
S$27.80 mln
 
FY Adjusted EBITDA
 
S$82.50 mln
 

Analyst Coverage
The one available analyst rating on the shares is "hold"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Thomson Medical Group Ltd is S$0.07, about 28.3% above its August 25 closing price of S$0.05

Reuters Recommended Reads
Aug 25 - China's Hospital Corporation half-year profit drops on service revenue decline
Aug 25 - C-Mer Eye Care's H1 revenue rises, net profit flat
Aug 26 - China's Consun Pharmaceutical H1 revenue rises on sales network expansion

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)